Lucas R. Johnson

Researcher

University of Arkansas for Medical Sciences

grad_student

1 h-index 3 pubs 1 cited

Is this your profile? Verify and claim your profile

Biography and Research Information

OverviewAI-generated summary

Lucas R. Johnson's research focuses on investigating physiological markers in patients with chronic kidney disease (CKD). His work examines the role of P2Y12 receptor inhibitors in mitigating sepsis-related hospitalizations among individuals with CKD. Additionally, Johnson has studied the elevated glycolysis levels observed in circulating leukocytes of CKD patients. His publications include "Potent P2Y12 Receptor Inhibitors Reduce Risk for Hospitalization from Sepsis in Patients with CKD" (2025) and "Higher Glycolysis in Circulating Leukocytes in Patients with CKD" (2024). Johnson has collaborated with Nishank Jain, Yasir Rahmatallah, and Dharmik Jadvani at the University of Arkansas for Medical Sciences.

Metrics

  • h-index: 1
  • Publications: 3
  • Citations: 1

Selected Publications

  • Potent P2Y12 Receptor Inhibitors Reduce Risk for Hospitalization from Sepsis in Patients with CKD (2025) DOI
  • Higher Glycolysis in Circulating Leukocytes in Patients with CKD (2024) DOI

Collaborators

Researchers in the database who share publications

Similar Researchers

Based on overlapping research topics